Clinical Trials on Blood Loss, Surgical in Australia

Total 4220 results

Nexel Co., Ltd.
Novotech (Australia) Pty Limited

Completed

A Study of NP-011 in Healthy Volunteers

Myocardial Infarction

Australia
Curtin University

Active, not recruiting

Long-term Use of CCB and Breast Cancer Risk

Breast Cancer | Hypertension,Essential

Australia
Flinders University
The Queen Elizabeth Hospital; Flinders Medical Centre; Royal Adelaide Hospital

Completed

Effect of Exercise Training on Protein Expression in Skeletal Muscle Tissue After Exercise in Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Royal Perth Hospital
The University of Western Australia

Recruiting

Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension (OHT)

Hypertension | Obesity

Australia
South Australian Health and Medical Research Institute
Flinders University

Completed

Do Iron Supplements Impact the Gut Microbiome of Women of Reproductive Age?

Iron-deficiency | Anemia | Microbial Colonization

Australia
Pharmosa Biopharm Inc.
Novotech (Australia) Pty Limited

Recruiting

Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults

Pulmonary Arterial Hypertension

Australia
Monash University
Curtin University; Flinders University; Ambulance Victoria; SA Ambulance Service; St John Ambulance Australia (Western Australia)

Unknown

Reduction of Oxygen After Cardiac Arrest (EXACT)

Out-of-Hospital Cardiac Arrest

Australia
The University of Western Australia

Unknown

High Density Lipoprotein (HDL) Functionality in Metabolic Syndrome

Metabolic Syndrome X

Australia
Infraredx
Royal Adelaide Hospital; South Australian Health and Medical Research Institute

Completed

In Vitro and In Vivo Comparison Between Intravascular Ultrasound (IVUS) Systems (SAVOIR2)

Coronary Artery Disease

Australia
Sir Charles Gairdner Hospital

Completed

Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients

Anemia | Kidney Failure, Chronic

Australia
Abbott Medical Devices

Completed

Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Patients (EnligHTN-I)

Hypertension

Australia, Greece
Ji Xing Pharmaceuticals Australia Pty Ltd
Novotech (Australia) Pty Limited

Recruiting

JX09 SAD/MAD in Healthy Participants

Resistant Hypertension

Australia
Resverlogix Corp
South Australian Health and Medical Research Institute

Terminated

Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia

Coronary Artery Disease | Dyslipidemia

Australia
Boston Scientific Corporation

Completed

Stenting of the Superficial Femoral and/or Proximal Popliteal Artery Project (MAJESTIC)

Atherosclerosis of Native Arteries of the Extremities

New Zealand, Germany, Belgium, Australia, Austria
Dizal Pharmaceuticals

Not yet recruiting

DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin

Australia
Alucent Biomedical

Active, not recruiting

Feasibility Study of the Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Popliteal Artery (PA) After Sub-optimal Percutaneous Transluminal Angioplasty (PTA) or Atherectomy: REACTIVATE I (REACTIVATE I)

PAD - Peripheral Arterial Disease

Australia
Peter MacCallum Cancer Centre, Australia
Melbourne Health

Completed

NMP in Relapsed / Refractory Myeloma

Multiple Myeloma

Australia
Abbott Medical Devices

Completed

HeartMate 3 CE Mark Study Long Term Follow-up (HM3 CE LTFU)

Advanced Refractory Left Ventricular Heart Failure

Germany, Canada, Austria, Czechia, Kazakhstan, Australia
Royal Perth Hospital
Royal Perth Hospital Medical Research Foundation

Completed

Behavioural Intervention for Dysphagia in Acute Stroke

Dysphagia

Australia
Biotronik CRC Inc.
Biotronik AG

Completed

BRight DCB First-in-Human Study

Peripheral Artery Disease

New Zealand, Australia, Germany, Austria
ImpediMed Limited

Completed

Assessment of Unilateral Lymphoedema of the Leg

Lymphedema

Australia
Australasian Leukaemia and Lymphoma Group
Merck Sharp & Dohme LLC; Novartis Pharmaceuticals

Unknown

Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia (PInNACLe)

Chronic Myeloid Leukaemia

Australia
Ichnos Sciences SA

Not yet recruiting

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

Australia
Peter MacCallum Cancer Centre, Australia
The Leukemia and Lymphoma Society

Completed

A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone

Lymphoma | Multiple Myeloma

Australia
Austin Health

Unknown

"Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery

Myocardial Ischemia | Coronary Artery Disease | Blood Coagulation Disorders | Heart Valve Diseases

Australia
Novo Nordisk A/S

Completed

Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease

Acquired Bleeding Disorder | Cardiac Surgery Requiring Cardiopulmonary Bypass

Australia
Bayside Health

Terminated

Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Australia
R.P.Herrmann

Completed

Assays for and Reversal of New Anticoagulants

Atrial Fibrillation | Osteoarthritis of the Hip | Osteoarthritis of the Knee

Australia
Arduino Mangoni

Completed

Mechanisms of Anti-VEGF Induced Hypertension

Renal Cancer

Australia
The Queen Elizabeth Hospital

Completed

Smoking Termination Opportunity for inPatients (STOP)

Tobacco Use Disorder

Australia
The Queen Elizabeth Hospital

Completed

Safety of Continuous Potassium Chloride Infusion in Critical Care (ASPIC)

Arrhythmias, Cardiac | Hypokalemia

Australia
Peter MacCallum Cancer Centre, Australia
Celgene Corporation

Unknown

A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression

Multiple Myeloma

Australia
GlaxoSmithKline

Withdrawn

A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma

Cancer

Australia
Peter MacCallum Cancer Centre, Australia
Celgene Corporation; Janssen-Cilag Ltd.

Unknown

A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma

Multiple Myeloma

Australia
Enyo Pharma
CPR Pharma Services Pty Ltd, Australia

Completed

Drug Drug Interaction Study for EYP001 With Entecavir

Hepatitis B, Chronic

Australia
Royal Adelaide Hospital
National Health and Medical Research Council, Australia; Sanofi

Unknown

Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People (Lixi)

Diabetes Mellitus | Gastroparesis

Australia
Royal Perth Hospital
ReCor Medical, Inc.

Recruiting

REducing Sympathetic Activity Through Ultrasound-based Renal deneRvation in Excessive Cardiovascular Risk populaTions. (RESURRECT)

Heart Failure | Chronic Kidney Diseases | End Stage Renal Disease

Australia
Celgene

Completed

NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma

Melanoma | Lymphoma | Multiple Myeloma | Pancreatic Cancer | Non-Small Cell Lung Cancer

Australia
Vascutek Ltd.

Active, not recruiting

Global Fenestrated Anaconda Clinical sTudy (Global FACT)

Abdominal Aortic Aneurysm

Netherlands, Canada, United Kingdom, Austria, Australia
ImpediMed Limited

Completed

The Equivalency of the Imp SFB7+ (L-Dex U400) With the Imp XCA Device

Lymphedema

Australia
Cibiem, Inc.

Unknown

First-In-Human Study Evaluating a Novel Catheter Device in Subjects With Treatment-Resistant Hypertension

Hypertension,Essential

Australia, Czechia, Germany
Bayside Health

Unknown

Atorvastatin in Myeloma

Myeloma

Australia
Flinders University

Recruiting

Role of Perhexiline in Hypertrophic Cardiomyopathy (RESOLVE-HCM)

Hypertrophic Cardiomyopathy

Australia
Kona Medical Inc.

Completed

A Safety Evaluation of Renal Denervation Using Focused Therapeutic Ultrasound on Patients With Refractory Hypertension

Hypertension

Australia
Imago BioSciences, Inc., a subsidiary of Merck...

Completed

A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

Australia
Cancer Trials Australia
Human Genome Sciences Inc.

Unknown

A Study of Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia

Symptomatic Waldenstroms Macroglobulinaemia

Australia
Cardiosonic

Unknown

Continued Safety and Performance of the TIVUS System

Hypertension, Resistant to Conventional Therapy

Australia
Novartis

Completed

Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension

Ocular Hypertension

Australia
Peter MacCallum Cancer Centre, Australia
Janssen, LP

Recruiting

CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study (CARAMEL)

Extramedullary Myeloma

Australia
Western Sydney Local Health District

Recruiting

Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia (CAAD-VT)

Ventricular Tachycardia | Cardiomyopathy, Dilated | Heart Disease Structural Disorder | Sarcoidosis | Cardiomyopathy, Hypertrophic | Cardiomyopathy, Familial | Cardiomyopathy Ischemic | Arrhythmogenic Right Ventricular Cardiomyopathy 1 | Arrhythmogenic Left Ventricular Cardiomyopathy

Australia

Clinical Trials on Blood Loss, Surgical in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations